- WHEN: 12:30 p.m., Thursday, Nov. 4
- WHERE: Central Park Ballroom I and II (adjoined) at the Inter Continental New York, Times Square, 300 W44th Street, New York City
- FEATURED SPEAKERS: Ambassador Han Duk-Su to the United States (former prime minister of Korea) KHIDI President Bup-wan Kim, KPMA President Lee Kyung-ho (Republic of Korea) PhRMA CEO John Castellani (the U.S.) etc.
- PURPOSE: Korea Health Industry Development Institute USA (KHIDI USA) hosted the US-Korea Pharma CEO forum to build networks between Korean and American pharmaceutical industry leaders, promote to pharmaceutical technology transfer, and exchange skilled employees between two countries. The forum also aimed to provide practical information to Korean CEOs to do business in the US market and introduce them prospective partners in the U.S
PROGRAM:
|
Time |
Topic |
Speaker |
|
|
Name |
Position |
||
|
Korea CEO Workshop _ Session 1 Bio/Pharma Regulations of the US (for Korean CEOs only) |
|||
|
8:00-8:30 |
US Korea CEO Forum Registration |
||
|
8:30 – 10:40 |
US Biotech industry overview and key issues(30) |
Cartier Esham |
VP, BIO (Biotechnology Industry Organization) |
|
US generic industry overview and collaboration opportunities (30) |
Shawn Brown |
VP, GPhA (Generic Pharmaceutical Association) |
|
|
Global trend of pharmceutical regulations (30) |
Mary Jane Nehring |
President, RHI (Regulatory Harmonizatin Institute) |
|
|
Panel Discussion (40) |
Mark Paxton, David Orloff et al. |
BIO, GPhA, RHI, MedPace |
|
|
10:40 – 11:00 |
Coffee Break |
||
|
Korea CEO Workshop _ Session 2 Distribution and Pricing in the US (for Korean CEOs only) |
|||
|
11:00 – 12:40 |
Pharmaceutical Distribution in the US (25) |
Craig Kephart |
CEO, Centric Health Resources |
|
Pharmaceutical Pricing system and status in the US (25) |
Dean P. Erhardt |
Principal, D2 Pharma LLC |
|
|
Economic consideration for establishing operation in the US (25) |
Christopher D. Lloyd |
Senior Vice President, McGuireWoods |
|
|
Outreaching to medical doctors’ community in the US (25) |
Chul-soo Hyun |
President elect, Korean American Medical Association |
|
|
13:00 – 14:30 |
Luncheon Remarks and Lunch Reception |
The Honrable Young-mok Kim |
Consul General, the Korean Consulate General New York |
|
Opening and Keynote Session |
|||
|
14:00 – 14:30 |
US Korea CEO Forum Registration |
||
|
14:30 – 14:40 |
Opening Remarks (10) |
Bup-wan Kim |
President, KHIDI |
|
14:40 – 14:50 |
Welcoming Address (10) |
Kyeong-ho Lee |
President, KPMA |
|
14:50 – 15:10 |
Keynote (1) The KORUS FTA and it’s implication for the U.S prarmaceutical Industry (20) |
The Honrable Duk-soo Han |
Republic of Korea Ambassador to the US |
|
15:10 – 15:30 |
Keynote (2) US-Korea Collaboration Opportunities in the Global Market (20) |
John Castellani |
CEO, PhRMA |
|
US Korea CEO Forum_Session 1 Global Competition and Collaboration |
|||
|
15:30 – 15:55 |
Business development opportunities with multinational company (25) |
Jorge Puente |
Regional President, Pfizer |
|
15:55 – 16:20 |
Pharma environment in Korea as collaboration destination (25) |
In-chull Kim |
CEO, LG Life Science |
|
16:20 – 16:40 |
Coffee Break |
||
|
US Korea CEO Forum _ Session 2 Pharma Business Environment of the US and Korea |
|||
|
16:40 – 17:05 |
Pharmaceutical Pricing Trend and Policy in the US (25) |
Stephen Schondelmeyer |
|